Moreover, tumors frequently deploy multiple immune evasion strategies, such as the expression of checkpoint proteins (e.g., PD-L1) that dampen immune responses, and the modulation of the tumor microenvironment to inhibit T-cell infiltration and activity (60). This evidence concerns the gene CD274 and neoplasm.